GLP-1 (Glucagon-Like Peptide-1) receptor agonists have transformed the treatment of Type 2 diabetes and obesity. Understanding how these How GLP-1 works helps patients make informed decisions about therapy and expectations.
🔗 Source: PubMed – GLP-1 Mechanism
1️⃣ What is GLP-1 And How GLP-1 works?
GLP-1 is a hormone produced naturally in the gut that:
- Stimulates insulin secretion after meals
- Suppresses glucagon release, lowering blood sugar
- Slows gastric emptying, increasing satiety
- Influences appetite centers in the brain
GLP-1 receptor agonists mimic these effects with longer-lasting action than the body’s natural hormone.
2️⃣ How GLP-1 Injections Work
GLP-1 drugs (e.g., Ozempic, Wegovy, Mounjaro) activate the GLP-1 receptor to:
- Increase insulin secretion only when glucose is high
- Reduce glucagon, preventing unnecessary glucose production
- Slow stomach emptying for better blood sugar control
- Suppress hunger signals to aid weight loss
3️⃣ Dual & Next-Generation Agonists
Emerging GLP-1 therapies like Mounjaro (tirzepatide) and Retatrutide combine GLP-1 with GIP or glucagon receptor activation:
- Enhance weight loss
- Improve glycemic control
- Boost energy expenditure beyond traditional GLP-1 agonists
🔗 Learn more: Nature – Dual Agonists
4️⃣ Clinical Benefits
- Weight reduction: Up to 15–20% in obesity trials
- Blood sugar control: HbA1c reductions of 1–2%
- Cardiovascular protection: Lower risk of heart attack and stroke for some GLP-1s
- Metabolic improvements: Fat reduction, improved liver markers
5️⃣ Side Effects & Safety
Mild GI side effects are common during dose escalation:
- Nausea or vomiting
- Diarrhea or constipation
- Reduced appetite
- Occasional fatigue
6️⃣ Takeaway
GLP-1 injections work by harnessing natural hormones to control blood sugar and appetite, making them highly effective for diabetes and weight management. Understanding the science helps patients and healthcare providers choose the right therapy and manage expectations.